Immediate Impact
1 from Science/Nature 65 standout
Citing Papers
Oesophageal cancer
2024 Standout
Mito‐Bomb: Targeting Mitochondria for Cancer Therapy
2021 Standout
Works of R Algeri being referenced
FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results
2000
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
1994
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| R Algeri | 222 | 102 | 171 | 127 | 25 | 443 | |
| Jacques Olivier Bay | 193 | 75 | 199 | 66 | 30 | 459 | |
| Schein Ps | 174 | 132 | 119 | 164 | 24 | 511 | |
| Matthew Hiemenz | 172 | 52 | 144 | 57 | 42 | 417 | |
| Olav Erich Yri | 209 | 196 | 102 | 114 | 20 | 466 | |
| P. Gobbi | 192 | 324 | 99 | 93 | 20 | 462 | |
| C Ghandour | 189 | 278 | 81 | 100 | 16 | 379 | |
| Jong Seok Lee | 213 | 107 | 144 | 45 | 18 | 469 | |
| H. S. Hochster | 421 | 112 | 126 | 62 | 21 | 507 | |
| M. Crump | 176 | 184 | 118 | 48 | 20 | 453 | |
| L North | 283 | 370 | 80 | 142 | 15 | 466 |
All Works
Loading papers...